In animal models of PD, neuroprotective effects have been demonstrated with the angiotensin-converting enzyme (ACE) inhibitors captopril and perindopril, as well as the AT1 receptor antagonists losartan, candesartan, and telmisartan. This evidence concerns the gene ACE and Parkinson disease.